Streptokinase
- Generic Name
- Streptokinase
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9002-01-1
- Unique Ingredient Identifier
- 8X1OXL3SNU
- Background
Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.
- Indication
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
- Associated Conditions
- Acute Myocardial Infarction (AMI), Arterial Thromboembolism, Arterial thrombosis, Arteriovenous fistula occlusion, Arteriovenous fistula thrombosis, Arteriovenous occlusions, Central Retinal Vein Occlusion (CRVO), Chronic Occlusive Arterial Disease, Deep Vein Thrombosis, Peripheral artery thrombosis, Pulmonary Embolism, Pulmonary Embolism Acute Massive, Pulmonary Thromboembolism, Acute Arterial Thromboembolism
- Associated Therapies
- -
Catheter Directed Interventions in Pulmonary Embolism
- Conditions
- Interventions
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 60
- Registration Number
- NCT03595085
Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
- Conditions
- Interventions
- First Posted Date
- 2018-03-14
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 60
- Registration Number
- NCT03465085
Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2017-06-06
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 100
- Registration Number
- NCT03172052
A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 49
- Registration Number
- NCT02182011
Asia Africa Streptokinase Trial
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- University of Alberta
- Registration Number
- NCT02150785
Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis
- Conditions
- Interventions
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2016-07-07
- Target Recruit Count
- 28
- Registration Number
- NCT01977118
- Locations
- 🇮🇳
Postgraduate Institute of Medical Education and Research, Chandigarh, India
Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis
- Conditions
- Interventions
- First Posted Date
- 2011-10-13
- Last Posted Date
- 2011-10-13
- Target Recruit Count
- 182
- Registration Number
- NCT01451320
- Locations
- 🇹🇷
Kosuyolu Kartal Heart Training and Research Hospital, Istanbul, Turkey
A Trial Using Double-Bolus THR-100 Versus Streptokinase
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 120
- Registration Number
- NCT01305226
- Locations
- 🇮🇳
Narayana Hrudayalaya, Bangalore, Karnataka, India
🇮🇳Sri Jayadeva Institute of Cardiology., Bangalore, Karnataka, India
🇮🇳Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, West Bengal, India
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
- Conditions
- Interventions
- First Posted Date
- 2008-03-03
- Last Posted Date
- 2009-06-23
- Lead Sponsor
- Istanbul University
- Target Recruit Count
- 53
- Registration Number
- NCT00627809
- Locations
- 🇹🇷
Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, Istanbul, Turkey
A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2013-10-24
- Target Recruit Count
- 120
- Registration Number
- NCT00232622
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.